Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect.

HCC MWA RFA complications imaging liver metastases

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
13 May 2022
Historique:
received: 17 04 2022
revised: 10 05 2022
accepted: 12 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

One of the major fields of application of ablation treatment is liver tumors. With respect to HCC, ablation treatments are considered as upfront treatments in patients with early-stage disease, while in colorectal liver metastases (CLM), they can be employed as an upfront treatment or in association with surgical resection. The main prognostic feature of ablation is the tumor size, since the goal of the treatment is the necrosis of all viable tumor tissue with an adequate tumor-free margin. Radiofrequency ablation (RFA) and microwave ablation (MWA) are the most employed ablation techniques. Ablation therapies in HCC and liver metastases have presented a challenge to radiologists, who need to assess response to determine complication-related treatment. Complications, defined as any unexpected variation from a procedural course, and adverse events, defined as any actual or potential injury related to the treatment, could occur either during the procedure or afterwards. To date, RFA and MWA have shown no statistically significant differences in mortality rates or major or minor complications. To reduce the rate of major complications, patient selection and risk assessment are essential. To determine the right cost-benefit ratio for the ablation method to be used, it is necessary to identify patients at high risk of infections, coagulation disorders and previous abdominal surgery interventions. Based on risk assessment, during the procedure as part of surveillance, the radiologists should pay attention to several complications, such as vascular, biliary, mechanical and infectious. Multiphase CT is an imaging tool chosen in emergency settings. The radiologist should report technical success, treatment efficacy, and complications. The complications should be assessed according to well-defined classification systems, and these complications should be categorized consistently according to severity and time of occurrence.

Identifiants

pubmed: 35628893
pii: jcm11102766
doi: 10.3390/jcm11102766
pmc: PMC9147303
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Radiol Med. 2021 Sep;126(9):1181-1188
pubmed: 34132926
Radiol Med. 2021 Aug;126(8):1129-1137
pubmed: 34057667
Cardiovasc Intervent Radiol. 2018 Jun;41(6):905-911
pubmed: 29484466
J Am Coll Surg. 2007 May;204(5):854-62; discussion 862-4
pubmed: 17481498
Int J Environ Res Public Health. 2021 May 24;18(11):
pubmed: 34073865
Radiol Oncol. 2019 Oct 25;53(4):373-387
pubmed: 31652122
Radiol Med. 2020 Aug;125(8):790-797
pubmed: 32206984
Int J Surg. 2015 Sep;21 Suppl 1:S78-82
pubmed: 26123385
Can Assoc Radiol J. 2018 Feb;69(1):51-62
pubmed: 29458955
Int J Surg. 2015 Jun;18:230-6
pubmed: 25917204
Radiol Med. 2020 Aug;125(8):754-762
pubmed: 32193870
Eur Radiol. 2020 May;30(5):2463-2472
pubmed: 32002642
IEEE Trans Med Imaging. 2020 May;39(5):1459-1471
pubmed: 31689185
Cardiovasc Intervent Radiol. 2021 Sep;44(9):1323-1353
pubmed: 34231007
J Gastrointest Surg. 2010 Aug;14(8):1285-91
pubmed: 20532666
Eur J Radiol. 2022 Mar;148:110163
pubmed: 35066340
Radiol Med. 2021 Jan;126(1):3-4
pubmed: 33502664
AJR Am J Roentgenol. 2015 May;204(5):1000-7
pubmed: 25905934
Radiol Med. 2020 Dec;125(12):1249-1259
pubmed: 32367320
Eur Radiol. 2021 May;31(5):3042-3052
pubmed: 33125554
Tech Vasc Interv Radiol. 2013 Dec;16(4):192-200
pubmed: 24238374
Eur J Radiol. 2021 Apr;137:109609
pubmed: 33647779
Radiol Med. 2022 Mar;127(3):277-293
pubmed: 35129758
Cardiovasc Intervent Radiol. 2020 Jun;43(6):918-923
pubmed: 32236668
Radiol Med. 2021 Jun;126(6):761-767
pubmed: 33715036
J Vasc Interv Radiol. 2021 Sep;32(9):1292-1295.e1
pubmed: 34462079
Radiol Med. 2021 Jul;126(7):1007-1016
pubmed: 33890201
Radiol Med. 2020 Jul;125(7):625-635
pubmed: 32125637
Cancers (Basel). 2020 Sep 18;12(9):
pubmed: 32961946
Radiol Med. 2020 Jun;125(6):578-584
pubmed: 32040718
Clin Hemorheol Microcirc. 2018;70(4):467-476
pubmed: 30347610
Anal Cell Pathol (Amst). 2019 Aug 26;2019:8619096
pubmed: 31534899
HPB (Oxford). 2013 Dec;15(12):985-90
pubmed: 23607636
Oncotarget. 2017 Jan 31;8(5):8143-8153
pubmed: 28042958
Radiol Med. 2020 Jul;125(7):609-617
pubmed: 32072390
Infect Agent Cancer. 2018 Jul 3;13:23
pubmed: 29988667
J Vasc Interv Radiol. 2020 Jul;31(7):1170-1177.e2
pubmed: 32171539
Radiol Med. 2020 Jun;125(6):595-599
pubmed: 32048156
Radiol Med. 2020 Dec;125(12):1233-1242
pubmed: 32424659
Biomedicines. 2022 Jan 26;10(2):
pubmed: 35203498
Mol Oncol. 2022 Jan;16(2):319-332
pubmed: 34668636
Radiol Med. 2021 Dec;126(12):1497-1507
pubmed: 34427861
Cardiovasc Intervent Radiol. 2018 Aug;41(8):1189-1204
pubmed: 29666906
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819876899
pubmed: 31533537
Radiol Med. 2022 Jan;127(1):21-29
pubmed: 34741722
Radiol Med. 2020 Apr;125(4):374-383
pubmed: 31916105
World J Gastroenterol. 2021 Jun 21;27(23):3413-3428
pubmed: 34163121
Cardiovasc Intervent Radiol. 2021 Dec;44(12):2022-2025
pubmed: 34414496
J Pers Med. 2021 Apr 08;11(4):
pubmed: 33917902
Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):9697-9706
pubmed: 31799635
Cancers (Basel). 2022 Jan 18;14(3):
pubmed: 35158749
IEEE Trans Biomed Eng. 2006 Jul;53(7):1409-15
pubmed: 16830945
Radiol Med. 2020 Jun;125(6):531-537
pubmed: 32020528
Radiol Med. 2020 Oct;125(10):971-980
pubmed: 32270335
Abdom Radiol (NY). 2021 Dec;46(12):5586-5597
pubmed: 34453180
Eur Radiol. 2017 May;27(5):1934-1943
pubmed: 27572812
Eur Radiol. 2018 May;28(5):1986-1993
pubmed: 29196855
Radiol Med. 2020 Nov;125(11):1087-1101
pubmed: 32978708
Int J Clin Oncol. 2013 Feb;18(1):46-53
pubmed: 22016114
Oncotarget. 2017 Apr 19;8(31):51224-51237
pubmed: 28881643
Int J Gynecol Cancer. 2016 Nov;26(9):1650-1657
pubmed: 27654262
Insights Imaging. 2018 Feb;9(1):1-7
pubmed: 29460129
Radiol Med. 2022 Feb;127(2):199-205
pubmed: 34890007
J Am Coll Radiol. 2019 Jan;16(1):30-38
pubmed: 30158081
Radiol Med. 2020 Aug;125(8):697-705
pubmed: 32200455
Radiol Med. 2021 Jul;126(7):925-935
pubmed: 33954894
Radiol Med. 2021 Dec;126(12):1584-1600
pubmed: 34843029
Radiol Med. 2021 Mar;126(3):466-473
pubmed: 32889704
Br J Radiol. 2022 Mar 1;95(1131):20210959
pubmed: 35179399
Radiol Med. 2021 Sep;126(9):1149-1158
pubmed: 34105102
Radiol Med. 2021 Jan;126(1):5-13
pubmed: 32458272
Radiol Med. 2021 Jan;126(1):55-62
pubmed: 32495272
Int J Surg. 2022 Jan;97:106194
pubmed: 34958968
Radiol Med. 2021 Dec;126(12):1619-1656
pubmed: 34570309
Insights Imaging. 2020 Aug 12;11(1):92
pubmed: 32785803
Radiol Med. 2021 Mar;126(3):460-465
pubmed: 32852750
Int J Surg. 2008;6 Suppl 1:S65-9
pubmed: 19186116
Radiol Med. 2021 Feb;126(2):323-333
pubmed: 32594427
Radiol Med. 2022 Jan;127(1):90-99
pubmed: 34697728
J Surg Oncol. 2011 Dec;104(7):822-9
pubmed: 21520094
Radiol Med. 2022 May;127(5):461-470
pubmed: 35347583
J Vasc Interv Radiol. 2014 Nov;25(11):1691-705.e4
pubmed: 25442132
Eur Rev Med Pharmacol Sci. 2021 Nov;25(21):6499-6528
pubmed: 34787854
Diagnostics (Basel). 2021 Aug 30;11(9):
pubmed: 34573911
Radiol Med. 2021 Sep;126(9):1189-1200
pubmed: 34129178
Radiol Med. 2016 Feb;121(2):122-31
pubmed: 26345332
Radiol Med. 2021 Mar;126(3):380-387
pubmed: 32897493
Radiol Med. 2021 Nov;126(11):1460-1467
pubmed: 34309765
Technol Cancer Res Treat. 2007 Feb;6(1):37-48
pubmed: 17241099
World J Gastroenterol. 2017 Jul 14;23(26):4767-4778
pubmed: 28765698
Cardiovasc Intervent Radiol. 2021 Dec;44(12):1973-1985
pubmed: 34414494
Radiol Med. 2020 Apr;125(4):348-355
pubmed: 31916102
Radiol Med. 2020 Mar;125(3):296-305
pubmed: 31845091
Radiology. 2021 Dec;301(3):533-540
pubmed: 34581627
Biomedicines. 2022 Feb 15;10(2):
pubmed: 35203660
Ultrasound Med Biol. 2021 Aug;47(8):2138-2156
pubmed: 34011451
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):7051-7057
pubmed: 32633399
BMC Cancer. 2018 Apr 6;18(1):397
pubmed: 29625559
Cardiovasc Intervent Radiol. 2022 Jun;45(6):873-878
pubmed: 35217890
Radiol Med. 2020 Jan;125(1):15-23
pubmed: 31587182
Radiol Med. 2021 Aug;126(8):1030-1036
pubmed: 33961187
Radiol Med. 2021 May;126(5):652-660
pubmed: 33389661
J Vasc Interv Radiol. 2020 Apr;31(4):667-673
pubmed: 32113797
J Gastrointest Surg. 2008 May;12(5):842-51
pubmed: 18266046
Radiol Med. 2021 Aug 12;:
pubmed: 34386897
Cancers (Basel). 2021 Apr 28;13(9):
pubmed: 33925250
J Thorac Dis. 2022 Jan;14(1):64-75
pubmed: 35242369
Radiol Med. 2020 Oct;125(10):907-917
pubmed: 32274620
Radiology. 2014 Oct;273(1):241-60
pubmed: 24927329
Eur J Radiol. 2017 Nov;96:65-73
pubmed: 29103478
Cardiovasc Intervent Radiol. 2019 Jun;42(6):893-904
pubmed: 30761411
Eur J Radiol. 2021 Oct;143:109944
pubmed: 34482176
Br J Surg. 2013 Jan;100(1):122-9
pubmed: 23175234
Eur Radiol. 2021 Sep;31(9):6489-6499
pubmed: 33447860
Radiol Med. 2020 Oct;125(10):951-960
pubmed: 32306201
Eur Radiol. 2022 Feb;32(2):1320-1329
pubmed: 34467453
Radiol Med. 2021 Feb;126(2):258-263
pubmed: 32661779
Diagnostics (Basel). 2021 Nov 03;11(11):
pubmed: 34829384
Technol Cancer Res Treat. 2007 Aug;6(4):295-300
pubmed: 17668936
Radiol Med. 2020 Nov;125(11):1024-1039
pubmed: 32930945
Radiol Med. 2021 Dec;126(12):1609-1618
pubmed: 34453276
Radiol Med. 2020 Sep;125(9):801-815
pubmed: 32249391
Radiol Med. 2020 Feb;125(2):165-176
pubmed: 31605354
Endoscopy. 2000 Aug;32(8):598-603
pubmed: 10935787
BMC Urol. 2022 Mar 2;22(1):28
pubmed: 35236338
J Med Ultrason (2001). 2020 Apr;47(2):265-277
pubmed: 31960190
Cardiovasc Intervent Radiol. 2012 Aug;35(4):868-74
pubmed: 21833809
Tech Vasc Interv Radiol. 2007 Mar;10(1):38-46
pubmed: 17980317
Radiol Med. 2022 Feb;127(2):154-161
pubmed: 35034318
Radiol Med. 2020 Oct;125(10):918-925
pubmed: 32319005
Oncologist. 2019 Oct;24(10):e990-e1005
pubmed: 31217342
Radiol Med. 2021 Dec;126(12):1553-1560
pubmed: 34533699
Sci Rep. 2019 Jul 29;9(1):10953
pubmed: 31358904
AJR Am J Roentgenol. 2021 Jul;217(1):W2-W3
pubmed: 34010037
Radiol Med. 2021 Dec;126(12):1544-1552
pubmed: 34518985
J Healthc Eng. 2021 Dec 20;2021:3123553
pubmed: 34966520
Radiology. 2009 Jun;251(3):933-40
pubmed: 19304921
Front Oncol. 2020 Nov 27;10:560952
pubmed: 33330028
Radiol Med. 2021 Jan;126(1):155-162
pubmed: 32405924
Radiol Med. 2021 Oct;126(10):1335-1344
pubmed: 34176050
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28376151
Future Oncol. 2018 Sep;14(21):2189-2206
pubmed: 30084273
Br J Radiol. 2022 Feb 01;95(1130):20210748
pubmed: 34797687
Eur Radiol. 2019 Mar;29(3):1293-1307
pubmed: 30255245
Eur Rev Med Pharmacol Sci. 2021 May;25(10):3684-3699
pubmed: 34109578
J Clin Med. 2021 Sep 04;10(17):
pubmed: 34501455
Infect Agent Cancer. 2015 Jul 29;10:22
pubmed: 26225138
Radiol Med. 2021 Jul;126(7):910-924
pubmed: 33954897
Radiol Med. 2010 Dec;115(8):1258-66
pubmed: 20852956
Br J Radiol. 2022 May 01;95(1133):20211379
pubmed: 35138914
Radiol Med. 2021 Dec;126(12):1660-1661
pubmed: 34919192
Diagn Interv Imaging. 2020 Nov;101(11):707-713
pubmed: 33012694
Radiol Med. 2021 Apr;126(4):561-569
pubmed: 33242204
World J Gastroenterol. 2017 Feb 7;23(5):906-918
pubmed: 28223736
Front Oncol. 2021 Aug 26;11:694102
pubmed: 34513676
Int J Environ Res Public Health. 2021 Mar 30;18(7):
pubmed: 33808466
Infect Agent Cancer. 2021 Jul 19;16(1):53
pubmed: 34281580
Radiol Med. 2021 Nov;126(11):1487-1495
pubmed: 34405340
Cardiovasc Intervent Radiol. 2020 Nov;43(11):1641-1649
pubmed: 32808201
Diagn Interv Imaging. 2021 Dec;102(12):699-707
pubmed: 34419388
Radiol Med. 2021 Nov;126(11):1434-1450
pubmed: 34338948
Radiol Med. 2021 Dec;126(12):1518-1531
pubmed: 34420142
Front Endocrinol (Lausanne). 2021 Nov 30;12:748944
pubmed: 34917023
Cardiovasc Intervent Radiol. 2021 Aug;44(8):1184-1193
pubmed: 33825059
Br J Radiol. 2019 Jul;92(1099):20180864
pubmed: 30845823
Infect Agent Cancer. 2015 Apr 10;10:11
pubmed: 25897320
Radiol Med. 2021 Dec;126(12):1561-1570
pubmed: 34415507
J Vasc Interv Radiol. 2020 Jun;31(6):943-952
pubmed: 32414570
Oncotarget. 2015 Oct 6;6(30):30394-407
pubmed: 26320185
Infect Agent Cancer. 2017 Oct 30;12:57
pubmed: 29093748
Eur J Surg Oncol. 2018 Oct;44(10):1603-1609
pubmed: 30017329
Radiol Med. 2020 Apr;125(4):384-397
pubmed: 31925704
Langenbecks Arch Surg. 2007 Jan;392(1):45-54
pubmed: 16983576
Gastroenterol Res Pract. 2013;2013:469097
pubmed: 24324487
Infect Agent Cancer. 2021 Jun 2;16(1):39
pubmed: 34078424
Radiol Med. 2020 Oct;125(10):1008-1011
pubmed: 32306200

Auteurs

Vincenza Granata (V)

Radiology Division, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Via Mariano Semmola, 80131 Naples, Italy.

Roberta Fusco (R)

Medical Oncology Division, Igea SpA, 80013 Naples, Italy.

Federica De Muzio (F)

Department of Medicine and Health Sciences V. Tiberio, University of Molise, 86100 Campobasso, Italy.

Carmen Cutolo (C)

Department of Medicine, Surgery and Dentistry, University of Salerno, 84084 Fisciano, Italy.

Sergio Venanzio Setola (SV)

Radiology Division, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Via Mariano Semmola, 80131 Naples, Italy.

Igino Simonetti (I)

Radiology Division, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Via Mariano Semmola, 80131 Naples, Italy.

Federica Dell'Aversana (F)

Division of Radiology, Università degli Studi della Campania Luigi Vanvitelli, 80138 Naples, Italy.

Francesca Grassi (F)

Division of Radiology, Università degli Studi della Campania Luigi Vanvitelli, 80138 Naples, Italy.

Federico Bruno (F)

Italian Society of Medical and Interventional Radiology (SIRM), SIRM Foundation, 20122 Milan, Italy.
Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, 67100 L'Aquila, Italy.

Andrea Belli (A)

Hepatobiliary Surgical Oncology Division, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Via Mariano Semmola, 80131 Naples, Italy.

Renato Patrone (R)

Hepatobiliary Surgical Oncology Division, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Via Mariano Semmola, 80131 Naples, Italy.

Vincenzo Pilone (V)

Department of Medicine, Surgery and Dentistry, University of Salerno, 84084 Fisciano, Italy.

Antonella Petrillo (A)

Radiology Division, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Via Mariano Semmola, 80131 Naples, Italy.

Francesco Izzo (F)

Hepatobiliary Surgical Oncology Division, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Via Mariano Semmola, 80131 Naples, Italy.

Classifications MeSH